Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model.

Sharma R, Earla B, Baidoo KE, Zeiger MA, Madigan JP, Escorcia FE, Sadowski SM
Mol Cancer Ther. 2023 Jul 22:MCT-22-0798. doi: 10.1158/1535-7163.MCT-22-0798. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.